General Wellness | Also Organics CBD

OCD (Obsessive Compulsive Disorder)

Osteoporosis/Bone Health

CBD Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts

Cannabinoid receptors as target for treatment of osteoporosis: A tale of two therapies

Cannabinoids and bone: Friend or foe?

Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells

Cannabinoids and the skeleton: From marijuana to reversal of bone loss

The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy

The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption

Endocannabinoids and the regulation of bone metabolism

Cannabinoid receptors and the regulation of bone mass

Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health

Peripheral cannabinoid receptor, CB2, regulates bone mass

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis

Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family

Parkinson's Disease

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial

Prospects for cannabinoid therapies in basal ganglia disorders

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease

Cannabidiol can improve complex sleep-related behaviors associated with rapid eye movement sleep behavior disorder in Parkinson’s disease patients

Cannabidiol for the treatment of psychosis in Parkinson’s disease

Therapeutic potential of cannabinoids in CNS disease

CB2 Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease

Neurological aspects of medical use of CBD

Prion Disease (Mad Cow)

Nonpsychoactive CBD prevents prion accumulation and protects neurons against prion toxicity

PTSD (Post Traumatic Stress Disorder)

The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD

Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks

Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear

Modulation of fear memory by dietary polyunsaturated fatty acids via cannabinoid receptors

CBD blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors

Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis

Cannabinoid modulation of fear extinction brain circuits: A novel target to advance anxiety treatment

The endocannabinoid system and extinction learning

A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers

Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit

Non-antidepressant long-term treatment in post-traumatic stress disorder

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system

The Use of Medicinal Marijuana for Posttraumatic Stress Disorder: A Review

CBD Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System

Bidirectional Effects of CBD on Contextual Fear Memory Extinction

CBD disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors

Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report

Rheumatism

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

Schizophrenia

CBD as an antipsychotic drug

Cannabidiol as a potential treatment for psychosis

CBD enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

Medical use of cannabis. CBD: A new light for schizophrenia

A critical review of the antipsychotic effects of CBD: 30 years of a translational investigation

Peripheral endocannabinoid system dysregulation in first-episode psychosis

Cannabinoids and schizophrenia

Antipsychotic-like effects of cannabidiol and rimonabant

CBD monotherapy for treatment-resistant schizophrenia

Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments

Improved Social Interaction, Recognition and Working Memory with CBD Treatment in a Prenatal Infection Rat Model.

Scleroderma

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.

Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis.

Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.

Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis

Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.

Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts.

EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.

Sickle Cell Anemia

Skin Conditions

Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis

CBD exerts sebostatic and anti-inflammatory effects on human sebocytes

The endocannabinoid system of the skin in health and disease

Epigenetic control of skin differentiation genes by phytocannabinoids

A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ

Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1

Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation

Attenuation of allergic contact dermatitis through the endocannabinoid system

Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus

The role of cannabinoids in dermatology

Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK

Spinal Cord Injury

Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury

Stroke

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury

Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism

Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism

Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function

Protective Effects of Cannabidiol Against Hippocampal Cell Death and Cognitive Impairment Induced by Bilateral Common Carotid Artery Occlusion in Mice

Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance

CBD reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke

Weight Loss

The impact of marijuana use on glucose, insulin, and insulin resistance among US adults

The potential use of cannabidiol in the therapy of metabolic syndrome

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes

Wellness

CBD: From an inactive cannabinoid to a drug with wide spectrum of action

CBD as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

CBD: An overview of some pharmacological aspects

CBD: An overview of some chemical and pharmacological aspects

The endocannabinoid system as an emerging target of pharmacotherapy

Therapeutic potential of cannabinoid-based drugs

Targeting the endocannabinoid system with cannabinoid receptor agonists

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

Therapeutic potential of cannabinoid-based drugs

Cannabinoids in clinical practice

Cannabinoids

Pharmacology of cannabinoids

Combined cannabinoid therapy via an oromucosal spray

Non-psychotropic plant cannabinoids

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology

Care and feeding of the endocannabinoid system

A tale of two cannabinoids

An update on safety and side effects of CBD: A review of clinical data and relevant animal studies

CBD, a novel inverse agonist for GPR12

General

CBD Critical Review Report – World Health Organization

Also organics full spectrum cbd

Our Products Are Featured In:

Get 15% off

Acne

ALS (Amyotrophic Lateral Sclerosis)

Anorexia

Antibiotic Resistance

Arthritis

Asthma

Atherosclerosis

Autoimmune Disease

Bipolar

Colitis & Crohn's Disease

Diabetes

Endocrine disorders

Glaucoma

Heart Disease

HIV & AIDS

Huntington's Disease (HD)

Irritable Bowel Syndrome (IBS)

Kidney Disease

Liver Disease

Migraines

Mood Disorders

Motion Sickness

Multiple Sclerosis (MS)

Nausea

Neurodegeneration

Obesity

OCD (Obsessive Compulsive Disorder)

Osteoporosis/Bone Health

Parkinson's Disease

Prion Disease (Mad Cow)

PTSD (Post Traumatic Stress Disorder)

Rheumatism

Scleroderma

Sickle Cell Anemia

Spinal Cord Injury

Stroke

Weight Loss

Wellness

General